Senescent Cells: A Therapeutic Target in Cardiovascular Diseases
Open accessThe DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
Abstract
Senescent cell accumulation has been observed in age-associated diseases including cardiovascular diseases. Senescent cells lack proliferative capacity and secrete senescence-associated secretory phenotype (SASP) factors that may cause or worsen many cardiovascular diseases. Therapies targeting senescent cells, especially senolytic drugs that selectively induce senescent cell removal, have been shown to delay, prevent, alleviate, or treat multiple age-associated diseases in preclinical models. Some senolytic clinical trials have already been completed or are underway for a number of diseases and geriatric syndromes. Understanding how cellular senescence affects the various cell types in the cardiovascular system, such as endothelial cells, vascular smooth muscle cells, fibroblasts, immune cells, progenitor cells, and cardiomyocytes, is important to facilitate translation of senotherapeutics into clinical interventions. This review highlights: (1) the characteristics of senescent cells and their involvement in cardiovascular diseases, focusing on the aforementioned cardiovascular cell types, (2) evidence about senolytic drugs and other senotherapeutics, and (3) the future path and clinical potential of senotherapeutics for cardiovascular diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · cited 1×
“For example, metformin, an established anti-diabetes medication, improves cardiovascular diseases [244] and cognitive dysfunction [245], attenuates cancer formation and resistance [246,247], and might increase lifespan [248].”
BackgroundLópez-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982 · cited 1×
“Many or most of these syndromes might be alleviated by targeting the hallmarks of aging [201].”
BackgroundThe serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508 · cited 1×
“Human cells have limited replicative potential, as discovered by Hayflick and Moorehead in 1961 [38].”
BackgroundHeart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Alonso, A., Beaton, A. Z., Bittencourt, M. S., Boehme, A. K., Buxton, A. E., Carson, A. P., Commodore-Mensah, Y., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001052 · Cited by 5,987
Inflamm‐aging: An Evolutionary Perspective on Immunosenescence
FRANCESCHI, C., BONAFÈ, M., VALENSIN, S., OLIVIERI, F., DE LUCA, M., OTTAVIANI, E., & DE BENEDICTIS, G. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06651.x · Cited by 5,358 · cited 1×
“Senescent-like T cells with the CD8+CD57+CD27−CD28null phenotype produce large amounts of IFN-γ and TNF-α and may promote inflammation in atherosclerotic disease [167].”
BackgroundCellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 1×
“, INK-ATTAC mice, from which highly p16Ink4a-expressing cells can be targeted for apoptosis using an agent, AP20187, that does not target cells without high expression of p16Ink4a [207].”
BackgroundSelf-citationCirculating endothelial progenitor cells, vascular function, and cardiovascular risk
Hill, J. M., Zalos, G., Halcox, J. P. J., Schenke, W. H., Waclawiw, M. A., Quyyumi, A. A., & Finkel, T. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022287 · Cited by 3,423
Cellular Senescence: Defining a Path Forward
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.005 · Cited by 3,225 · cited 1×
“There are currently no highly sensitive and specific individual markers for senescent cardiovascular cells in vivo [68].”
BackgroundEvidence for Cardiomyocyte Renewal in Humans
Bergmann, O., Bhardwaj, R. D., Bernard, S., Zdunek, S., Barnabé-Heider, F., Walsh, S., Zupicich, J., Alkass, K., Buchholz, B. A., Druid, H., et al. (2009) · Science · doi:10.1126/science.1164680 · Cited by 3,130
Research works printed but not linked: 165
- Yu, 2021, Quercetin Reverses Cardiac Systolic Dysfunction in Mice Fed with a High-Fat Diet: Role of Angiogenesis, Oxid. Med. Cell. Longev., 2021, 8875729, 10.1155/2021/8875729 · DOI · Paper page
- Gunasekaran, 2011, Type 2 diabetes and the aging pancreatic beta cell, Aging, 3, 565, 10.18632/aging.100350 · DOI · Paper page
- Palmer, 2022, Targeting cellular senescence in metabolic disease, Mol. Metab., 66, 101601, 10.1016/j.molmet.2022.101601 · DOI
- Chaib, 2022, Obesity, Senescence, and Senolytics, Handb. Exp. Pharmacol., 274, 165, 10.1007/164_2021_555 · DOI · Paper page
- Conley, 2020, Human Obesity Induces Dysfunction and Early Senescence in Adipose Tissue-Derived Mesenchymal Stromal/Stem Cells, Front. Cell Dev. Biol., 8, 197, 10.3389/fcell.2020.00197 · DOI · Paper page
- Escande, 2014, Deleted in Breast Cancer 1 regulates cellular senescence during obesity, Aging Cell, 13, 951, 10.1111/acel.12235 · DOI · Paper page
- Meijnikman, 2022, Hyperinsulinemia Is Highly Associated With Markers of Hepatocytic Senescence in Two Independent Cohorts, Diabetes, 71, 1929, 10.2337/db21-1076 · DOI
- Nalysnyk, 2012, Incidence and prevalence of idiopathic pulmonary fibrosis: Review of the literature, Eur. Respir. Rev., 21, 355, 10.1183/09059180.00002512 · DOI · Paper page
- Parikh, 2019, Hyperoxia-induced Cellular Senescence in Fetal Airway Smooth Muscle Cells, Am. J. Respir. Cell Mol. Biol., 61, 51, 10.1165/rcmb.2018-0176OC · DOI · Paper page
- Bian, 2019, Senescence marker activin A is increased in human diabetic kidney disease: Association with kidney function and potential implications for therapy, BMJ Open. Diabetes Res. Care, 7, e000720, 10.1136/bmjdrc-2019-000720 · DOI · Paper page
- Farr, 2019, Independent Roles of Estrogen Deficiency and Cellular Senescence in the Pathogenesis of Osteoporosis: Evidence in Young Adult Mice and Older Humans, J. Bone Miner. Res., 34, 1407, 10.1002/jbmr.3729 · DOI · Paper page
- Chirinos, J.A. (2022). Textbook of Arterial Stiffness and Pulsatile Hemodynamics in Health and Disease, Academic Press. · DOI
- Hwang, H.J., Kim, N., Herman, A.B., Gorospe, M., and Lee, J.S. (2022). Factors and Pathways Modulating Endothelial Cell Senescence in Vascular Aging. Int. J. Mol. Sci., 23. · DOI
- Yoshida, Y., Hayashi, Y., Suda, M., Tateno, K., Okada, S., Moriya, J., Yokoyama, M., Nojima, A., Yamashita, M., and Kobayashi, Y. (2014). Notch Signaling Regulates the Lifespan of Vascular Endothelial Cells via a p16-Dependent Pathway. PLoS ONE, 9. · DOI
- Kunieda, 2006, Angiotensin II induces premature senescence of vascular smooth muscle cells and accelerates the development of atherosclerosis via a p21-dependent pathway, Circulation, 114, 953, 10.1161/CIRCULATIONAHA.106.626606 · DOI · Paper page
- Miyauchi, 2004, Akt negatively regulates the in vitro lifespan of human endothelial cells via a p53/p21-dependent pathway, EMBO J., 23, 212, 10.1038/sj.emboj.7600045 · DOI · Paper page
- Breitschopf, 2001, Pro-atherogenic factors induce telomerase inactivation in endothelial cells through an Akt-dependent mechanism, FEBS Lett., 493, 21, 10.1016/S0014-5793(01)02272-4 · DOI · Paper page
- Rajendran, 2019, Autophagy and senescence: A new insight in selected human diseases, J. Cell. Physiol., 234, 21485, 10.1002/jcp.28895 · DOI · Paper page
- Bernadotte, 2016, Markers of cellular senescence. Telomere shortening as a marker of cellular senescence, Aging, 8, 3, 10.18632/aging.100871 · DOI · Paper page
- Hu, 2022, Cellular Senescence in Cardiovascular Diseases: A Systematic Review, Aging Dis., 13, 103, 10.14336/AD.2021.0927 · DOI · Paper page
- Conover, 2022, Senescence induces proteolytically-active PAPP-A secretion and association with extracellular vesicles in human pre-adipocytes, Exp. Gerontol., 172, 112070, 10.1016/j.exger.2022.112070 · DOI
- Conover, 2012, Key questions and answers about pregnancy-associated plasma protein-A, Trends Endocrinol. Metab., 23, 242, 10.1016/j.tem.2012.02.008 · DOI · Paper page
- Conover, 2015, Pregnancy-associated plasma protein-A deficiency improves survival of mice on a high fat diet, Exp. Gerontol., 70, 131, 10.1016/j.exger.2015.08.007 · doi:10.1016/j.exger.2015.08.007
- Conover, 2013, Preferential impact of pregnancy-associated plasma protein-A deficiency on visceral fat in mice on high-fat diet, Am. J. Physiol. Endocrinol. Metab., 305, E1145, 10.1152/ajpendo.00405.2013 · DOI
- Bale, 2017, Inducible knockdown of pregnancy-associated plasma protein-A gene expression in adult female mice extends life span, Aging Cell, 16, 895, 10.1111/acel.12624 · DOI
- Tanaka, 2021, Senescence-associated extracellular vesicle release plays a role in senescence-associated secretory phenotype (SASP) in age-associated diseases, J. Biochem., 169, 147, 10.1093/jb/mvaa109 · DOI
- Misawa, T., Hitomi, K., Miyata, K., Tanaka, Y., Fujii, R., Chiba, M., Loo, T.M., Hanyu, A., Kawasaki, H., and Kato, H. (2023). Identification of Novel Senescent Markers in Small Extracellular Vesicles. Int. J. Mol. Sci., 24. · DOI
- Munk, 2017, Senescence-Associated MicroRNAs, Int. Rev. Cell Mol. Biol., 334, 177, 10.1016/bs.ircmb.2017.03.008 · DOI
- Sato, 2022, CD153/CD30 signaling promotes age-dependent tertiary lymphoid tissue expansion and kidney injury, Journal. Clin. Investig., 132, e146071, 10.1172/JCI146071 · DOI · Paper page
- Toya, 2021, Vascular Aging Detected by Peripheral Endothelial Dysfunction Is Associated With ECG-Derived Physiological Aging, J. Am. Heart Assoc., 10, e018656, 10.1161/JAHA.120.018656 · DOI
- Kotla, 2019, Endothelial senescence is induced by phosphorylation and nuclear export of telomeric repeat binding factor 2-interacting protein, JCI Insight, 4, e124867, 10.1172/jci.insight.124867 · DOI
- Mortuza, R., Chen, S., Feng, B., Sen, S., and Chakrabarti, S. (2013). High glucose induced alteration of SIRTs in endothelial cells causes rapid aging in a p300 and FOXO regulated pathway. PLoS ONE, 8. · DOI · Paper page
- Liu, 2020, Glucose-induced oxidative stress and accelerated aging in endothelial cells are mediated by the depletion of mitochondrial SIRTs, Physiol. Rep., 8, e14331, 10.14814/phy2.14331 · DOI · Paper page
- Clayton, 2020, Doxorubicin-Induced Oxidative Stress and Endothelial Dysfunction in Conduit Arteries Is Prevented by Mitochondrial-Specific Antioxidant Treatment, Cardio Oncol., 2, 475
- Clayton, 2021, Tumor Necrosis Factor Alpha-Mediated Inflammation and Remodeling of the Extracellular Matrix Underlies Aortic Stiffening Induced by the Common Chemotherapeutic Agent Doxorubicin, Hypertension, 77, 1581, 10.1161/HYPERTENSIONAHA.120.16759 · DOI
- Dagher, 2021, Design of a Randomized Placebo-Controlled Trial to Evaluate the Anti-inflammatory and Senolytic Effects of Quercetin in Patients Undergoing Coronary Artery Bypass Graft Surgery, Front. Cardiovasc. Med., 8, 741542, 10.3389/fcvm.2021.741542 · DOI
- Vasa, 2000, Nitric oxide activates telomerase and delays endothelial cell senescence, Circ. Res., 87, 540, 10.1161/01.RES.87.7.540 · DOI · Paper page
- Yokoyama, 2019, p53 plays a crucial role in endothelial dysfunction associated with hyperglycemia and ischemia, J. Mol. Cell. Cardiol., 129, 105, 10.1016/j.yjmcc.2019.02.010 · DOI
- Yokoyama, 2014, Inhibition of endothelial p53 improves metabolic abnormalities related to dietary obesity, Cell Rep., 7, 1691, 10.1016/j.celrep.2014.04.046 · DOI · Paper page
- Hayashi, 2006, Endothelial cellular senescence is inhibited by nitric oxide: Implications in atherosclerosis associated with menopause and diabetes, Proc. Natl. Acad. Sci. USA, 103, 17018, 10.1073/pnas.0607873103 · DOI · Paper page
- Bloom, 2023, Mechanisms and consequences of endothelial cell senescence, Nat. Rev. Cardiol., 20, 38, 10.1038/s41569-022-00739-0 · DOI · Paper page
- Donato, 2009, Vascular endothelial dysfunction with aging: Endothelin-1 and endothelial nitric oxide synthase, Am. J. Physiol.-Heart Circ. Physiol., 297, H425, 10.1152/ajpheart.00689.2008 · DOI · Paper page
- 2001, The endothelium as a metabolic and endocrine organ: Its relation with insulin resistance, Exp. Clin. Endocrinol. Diabetes, 109, S166, 10.1055/s-2001-18579 · doi:10.1055/s-2001-18579
- Garfinkel, 1994, Post-transcriptional regulation of interleukin 1 alpha in various strains of young and senescent human umbilical vein endothelial cells, Proc. Natl. Acad. Sci. USA, 91, 1559, 10.1073/pnas.91.4.1559 · DOI · Paper page
- Matacchione, 2021, Anti-SASP and anti-inflammatory activity of resveratrol, curcumin and β-caryophyllene association on human endothelial and monocytic cells, Biogerontology, 22, 297, 10.1007/s10522-021-09915-0 · DOI
- Culley, 2021, Frataxin deficiency promotes endothelial senescence in pulmonary hypertension, J. Clin. Investig., 131, e136459, 10.1172/JCI136459 · DOI
- Chang, 2013, Telomerase- and angiogenesis-related gene responses to irradiation in human umbilical vein endothelial cells, Int. J. Mol. Med., 31, 1202, 10.3892/ijmm.2013.1300 · DOI
- Suda, M., Shimizu, I., Yoshida, Y., Hayashi, Y., Ikegami, R., Katsuumi, G., Wakasugi, T., Yoshida, Y., Okuda, S., and Soga, T. (2017). Inhibition of dipeptidyl peptidase-4 ameliorates cardiac ischemia and systolic dysfunction by up-regulating the FGF-2/EGR-1 pathway. PLoS ONE, 12. · DOI
- Sano, 2007, p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload, Nature, 446, 444, 10.1038/nature05602 · DOI · Paper page
- Chi, 2019, Vascular smooth muscle cell senescence and age-related diseases: State of the art, Biochim. Biophys. Acta Mol. Basis Dis., 1865, 1810, 10.1016/j.bbadis.2018.08.015 · DOI · Paper page
- Bennett, 1998, Cooperative interactions between RB and p53 regulate cell proliferation, cell senescence, and apoptosis in human vascular smooth muscle cells from atherosclerotic plaques, Circ. Res., 82, 704, 10.1161/01.RES.82.6.704 · DOI · Paper page
- Yu, 2016, The role of mitochondrial DNA damage in the development of atherosclerosis, Free. Radic. Biol. Med., 100, 223, 10.1016/j.freeradbiomed.2016.06.011 · DOI
- Canugovi, 2019, Increased mitochondrial NADPH oxidase 4 (NOX4) expression in aging is a causative factor in aortic stiffening, Redox Biol., 26, 101288, 10.1016/j.redox.2019.101288 · DOI
- Otuki, 2018, Effects of Direct Oral Anticoagulants at the Peak Phase, Trough Phase, and After Vascular Injury, J. Am. Coll. Cardiol., 71, 102, 10.1016/j.jacc.2017.10.076 · doi:10.1016/j.jacc.2017.10.076
- Hayashi, 2022, Coagulation factors promote brown adipose tissue dysfunction and abnormal systemic metabolism in obesity, iScience, 25, 104547, 10.1016/j.isci.2022.104547 · DOI
- Bennett, 2016, Basic research: Killing the old: Cell senescence in atherosclerosis, Nat. Rev. Cardiol., 14, 8, 10.1038/nrcardio.2016.195 · DOI
- Furuuchi, 2022, Endothelial SIRT-1 has a critical role in the maintenance of capillarization in brown adipose tissue, iScience, 25, 105424, 10.1016/j.isci.2022.105424 · DOI
- Grootaert, 2021, SIRT6 Protects Smooth Muscle Cells From Senescence and Reduces Atherosclerosis, Circ. Res., 128, 474, 10.1161/CIRCRESAHA.120.318353 · DOI · Paper page
- Gardner, 2015, Senescent Vascular Smooth Muscle Cells Drive Inflammation Through an Interleukin-1α-Dependent Senescence-Associated Secretory Phenotype, Arterioscler. Thromb. Vasc. Biol., 35, 1963, 10.1161/ATVBAHA.115.305896 · DOI · Paper page
- Soto, 2014, Aging in blood vessels. Medicinal agents FOR systemic arterial hypertension in the elderly, Ageing Res. Rev., 18, 132, 10.1016/j.arr.2014.10.001 · DOI
- Lacolley, 2017, Vascular Smooth Muscle Cells and Arterial Stiffening: Relevance in Development, Aging, and Disease, Physiol. Rev., 97, 1555, 10.1152/physrev.00003.2017 · DOI · Paper page
- Lacolley, 2018, Smooth muscle cell and arterial aging: Basic and clinical aspects, Cardiovasc. Res., 114, 513, 10.1093/cvr/cvy009 · DOI · Paper page
- Schurgers, 2018, Initiation and Propagation of Vascular Calcification Is Regulated by a Concert of Platelet- and Smooth Muscle Cell-Derived Extracellular Vesicles, Front. Cardiovasc. Med., 5, 36, 10.3389/fcvm.2018.00036 · DOI
- Ikeda, 2009, Replicative senescence of vascular smooth muscle cells enhances the calcification through initiating the osteoblastic transition, Am. J. Physiol. Heart Circ. Physiol., 297, H1673, 10.1152/ajpheart.00455.2009 · DOI · Paper page
- Huang, 2020, Carnosine attenuates vascular smooth muscle cells calcification through mTOR signaling pathway, Aging Med., 3, 153, 10.1002/agm2.12125 · DOI
- Wakasugi, T., Shimizu, I., Yoshida, Y., Hayashi, Y., Ikegami, R., Suda, M., Katsuumi, G., Nakao, M., Hoyano, M., and Kashimura, T. (2019). Role of smooth muscle cell p53 in pulmonary arterial hypertension. PLoS ONE, 14. · DOI
- Ball, 2005, Telomere-independent cellular senescence in human fetal cardiomyocytes, Aging Cell, 4, 21, 10.1111/j.1474-9728.2004.00137.x · DOI
- Mitry, 2020, Accelerated cardiomyocyte senescence contributes to late-onset doxorubicin-induced cardiotoxicity, Am. J. Physiol. Cell Physiol., 318, C380, 10.1152/ajpcell.00073.2019 · DOI
- Zhang, 2007, Hypoxia reoxygenation induces premature senescence in neonatal SD rat cardiomyocytes, Acta Pharmacol. Sin., 28, 44, 10.1111/j.1745-7254.2007.00488.x · DOI
- Nomura, 2018, Cardiomyocyte gene programs encoding morphological and functional signatures in cardiac hypertrophy and failure, Nat. Commun., 9, 4435, 10.1038/s41467-018-06639-7 · DOI · Paper page
- Spallarossa, 2009, Doxorubicin induces senescence or apoptosis in rat neonatal cardiomyocytes by regulating the expression levels of the telomere binding factors 1 and 2, Am. J. Physiol. Heart Circ. Physiol., 297, H2169, 10.1152/ajpheart.00068.2009 · DOI · Paper page
- Maejima, 2008, Induction of premature senescence in cardiomyocytes by doxorubicin as a novel mechanism of myocardial damage, Aging Cell, 7, 125, 10.1111/j.1474-9726.2007.00358.x · DOI · Paper page
- Massion, 2003, Nitric Oxide and Cardiac Function, Circ. Res., 93, 388, 10.1161/01.RES.0000088351.58510.21 · DOI · Paper page
- Shimizu, 2012, p53-induced adipose tissue inflammation is critically involved in the development of insulin resistance in heart failure, Cell Metab., 15, 51, 10.1016/j.cmet.2011.12.006 · DOI · Paper page
- Tang, 2020, Cardiomyocyte Senescence and Cellular Communications Within Myocardial Microenvironments, Front. Endocrinol., 11, 280, 10.3389/fendo.2020.00280 · DOI · Paper page
- Cui, 2018, Postinfarction Hearts Are Protected by Premature Senescent Cardiomyocytes Via GATA 4-Dependent CCN 1 Secretion, J. Am. Heart Assoc., 7, e009111, 10.1161/JAHA.118.009111 · DOI · Paper page
- Zhang, 2019, Trimetazidine and l-carnitine prevent heart aging and cardiac metabolic impairment in rats via regulating cardiac metabolic substrates, Exp. Gerontol., 119, 120, 10.1016/j.exger.2018.12.019 · DOI
- Dillon, 2012, The role of PGC-1 coactivators in aging skeletal muscle and heart, IUBMB Life, 64, 231, 10.1002/iub.608 · DOI · Paper page
- Mailleux, 2018, AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation, Nat. Commun., 9, 374, 10.1038/s41467-017-02795-4 · DOI · Paper page
- Tang, 2017, SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy, Circulation, 136, 2051, 10.1161/CIRCULATIONAHA.117.028728 · DOI · Paper page
- Kane, 2018, Sirtuins and NAD(+) in the Development and Treatment of Metabolic and Cardiovascular Diseases, Circ. Res., 123, 868, 10.1161/CIRCRESAHA.118.312498 · DOI · Paper page
- Burke, 1997, Coronary risk factors and plaque morphology in men with coronary disease who died suddenly, N. Engl. J. Med., 336, 1276, 10.1056/NEJM199705013361802 · DOI · Paper page
- Libby, 2008, Diversity of Denizens of the Atherosclerotic Plaque, Circulation, 117, 3168, 10.1161/CIRCULATIONAHA.108.783068 · DOI · Paper page
- Newby, 2009, Vulnerable atherosclerotic plaque metalloproteinases and foam cell phenotypes, Thromb. Haemost., 101, 1006, 10.1160/TH08-07-0469 · DOI · Paper page
- Johnson, 2006, Vascular calcification: Pathobiological mechanisms and clinical implications, Circ. Res., 99, 1044, 10.1161/01.RES.0000249379.55535.21 · DOI · Paper page
- Allahverdian, 2018, Smooth muscle cell fate and plasticity in atherosclerosis, Cardiovasc. Res., 114, 540, 10.1093/cvr/cvy022 · DOI · Paper page
- Childs, 2016, Senescent intimal foam cells are deleterious at all stages of atherosclerosis, Science, 354, 472, 10.1126/science.aaf6659 · DOI · Paper page
- Richardson, 2018, Telomerase Mediates Lymphocyte Proliferation but Not the Atherosclerosis-Suppressive Potential of Regulatory T-Cells, Arterioscler. Thromb. Vasc. Biol., 38, 1283, 10.1161/ATVBAHA.117.309940 · DOI
- Bernal, 2019, T cell senescence predicts subclinical atherosclerosis in HIV-infected patients similarly to traditional cardiovascular risk factors, Antiviral Res., 162, 163, 10.1016/j.antiviral.2018.12.014 · DOI
- Yu, 2016, T cell senescence and cardiovascular diseases, Clin. Exp. Med., 16, 257, 10.1007/s10238-015-0376-z · DOI · Paper page
- Varricchi, 2020, The emerging role of T follicular helper (T(FH)) cells in aging: Influence on the immune frailty, Ageing Res. Rev., 61, 101071, 10.1016/j.arr.2020.101071 · DOI
- Bazioti, 2022, T cell cholesterol efflux suppresses apoptosis and senescence and increases atherosclerosis in middle aged mice, Nat. Commun., 13, 3799, 10.1038/s41467-022-31135-4 · DOI · Paper page
- Youn, 2013, Immunosenescent CD8+ T cells and C-X-C chemokine receptor type 3 chemokines are increased in human hypertension, Hypertension, 62, 126, 10.1161/HYPERTENSIONAHA.113.00689 · DOI · Paper page
- Youn, 2015, Characterization of CD8(+)CD57(+) T cells in patients with acute myocardial infarction, Cell. Mol. Immunol., 12, 466, 10.1038/cmi.2014.74 · DOI
- Kaplan, 2011, T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women, J. Infect. Dis., 203, 452, 10.1093/infdis/jiq071 · DOI · Paper page
- Liuzzo, 2007, Unusual CD4+CD28null T lymphocytes and recurrence of acute coronary events, J. Am. Coll. Cardiol., 50, 1450, 10.1016/j.jacc.2007.06.040 · DOI · Paper page
- Asahara, 1997, Isolation of putative progenitor endothelial cells for angiogenesis, Science, 275, 964, 10.1126/science.275.5302.964 · DOI · Paper page
- Takahashi, 1999, Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization, Nat. Med., 5, 434, 10.1038/7434 · DOI · Paper page
- Werner, 2006, Clinical and therapeutical implications of EPC biology in atherosclerosis, J. Cell. Mol. Med., 10, 318, 10.1111/j.1582-4934.2006.tb00402.x · DOI
- Vasa, 2001, Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease, Circ. Res., 89, E1, 10.1161/hh1301.093953 · DOI · Paper page
- Yang, 1999, Human endothelial cell life extension by telomerase expression, J. Biol. Chem., 274, 26141, 10.1074/jbc.274.37.26141 · DOI · Paper page
- Torella, 2004, Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression, Circ. Res., 94, 514, 10.1161/01.RES.0000117306.10142.50 · DOI · Paper page
- Cesselli, 2011, Effects of age and heart failure on human cardiac stem cell function, Am. J. Pathol., 179, 349, 10.1016/j.ajpath.2011.03.036 · DOI · Paper page
- Castaldi, 2017, Decline in cellular function of aged mouse c-kit(+) cardiac progenitor cells, J. Physiol., 595, 6249, 10.1113/JP274775 · DOI
- Marino, 2022, Diabetes-Induced Cellular Senescence and Senescence-Associated Secretory Phenotype Impair Cardiac Regeneration and Function Independently of Age, Diabetes, 71, 1081, 10.2337/db21-0536 · DOI
- Zhu, F., Li, Y., Zhang, J., Piao, C., Liu, T., Li, H.H., and Du, J. (2013). Senescent cardiac fibroblast is critical for cardiac fibrosis after myocardial infarction. PLoS ONE, 8. · DOI · Paper page
- Jia, 2017, Haplodeficiency of Ataxia Telangiectasia Mutated Accelerates Heart Failure After Myocardial Infarction, J. Am. Heart Assoc., 6, e006349, 10.1161/JAHA.117.006349 · DOI · Paper page
- Li, K., Li, Y., Yu, Y., Ding, J., Huang, H., Chu, C., Hu, L., Yu, Y., Cao, Y., and Xu, P. (2021). Bmi-1 alleviates adventitial fibroblast senescence by eliminating ROS in pulmonary hypertension. BMC Pulm. Med., 21. · DOI
- Roger, I., Milara, J., Belhadj, N., and Cortijo, J. (2021). Senescence Alterations in Pulmonary Hypertension. Cells, 10. · DOI
- Sawaki, 2018, Visceral Adipose Tissue Drives Cardiac Aging Through Modulation of Fibroblast Senescence by Osteopontin Production, Circulation, 138, 809, 10.1161/CIRCULATIONAHA.117.031358 · DOI · Paper page
- Kamo, 2015, Cardiac nonmyocytes in the hub of cardiac hypertrophy, Circ. Res., 117, 89, 10.1161/CIRCRESAHA.117.305349 · DOI · Paper page
- Kakkar, 2010, Intramyocardial fibroblast myocyte communication, Circ. Res., 106, 47, 10.1161/CIRCRESAHA.109.207456 · DOI · Paper page
- Civitarese, 2017, Role of integrins in mediating cardiac fibroblast-cardiomyocyte cross talk: A dynamic relationship in cardiac biology and pathophysiology, Basic. Res. Cardiol., 112, 6, 10.1007/s00395-016-0598-6 · DOI
- Shibamoto, 2019, Activation of DNA Damage Response and Cellular Senescence in Cardiac Fibroblasts Limit Cardiac Fibrosis After Myocardial Infarction, Int. Heart J., 60, 944, 10.1536/ihj.18-701 · DOI
- Xie, 2015, Mitochondrial oxidative stress promotes atrial fibrillation, Sci. Rep., 5, 11427, 10.1038/srep11427 · DOI · Paper page
- Chang, 2008, Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer, Br. J. Cancer, 99, 1074, 10.1038/sj.bjc.6604676 · DOI · Paper page
- Xi, 2012, Eph receptors and ephrins as targets for cancer therapy, J. Cell. Mol. Med., 16, 2894, 10.1111/j.1582-4934.2012.01612.x · DOI · Paper page
- Johmura, 2021, Senolysis by glutaminolysis inhibition ameliorates various age-associated disorders, Science, 371, 265, 10.1126/science.abb5916 · DOI · Paper page
- Suda, 2022, Glycoprotein nonmetastatic melanoma protein B regulates lysosomal integrity and lifespan of senescent cells, Sci. Rep., 12, 6522, 10.1038/s41598-022-10522-3 · DOI · Paper page
- Minamino, 2009, A crucial role for adipose tissue p53 in the regulation of insulin resistance, Nat. Med., 15, 1082, 10.1038/nm.2014 · DOI · Paper page
- Flores, 2001, Tumor susceptibility of p21(Waf1/Cip1)-deficient mice, Cancer Res., 61, 6234
- Takahashi, 2006, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell, 126, 663, 10.1016/j.cell.2006.07.024 · DOI · Paper page
- Zhang, 2011, A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects, Cell Stem Cell, 8, 31, 10.1016/j.stem.2010.12.002 · DOI · Paper page
- Abad, 2013, Reprogramming in vivo produces teratomas and iPS cells with totipotency features, Nature, 502, 340, 10.1038/nature12586 · DOI · Paper page
- UK Prospective Diabetes Study (UKPDS) Group (1998). Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet, 352, 854–865. · DOI · Paper page
- Wang, 2010, Rad as a novel regulator of excitation-contraction coupling and beta-adrenergic signaling in heart, Circ. Res., 106, 317, 10.1161/CIRCRESAHA.109.208272 · DOI · Paper page
- Hurez, 2015, Chronic mTOR inhibition in mice with rapamycin alters T, B, myeloid, and innate lymphoid cells and gut flora and prolongs life of immune-deficient mice, Aging Cell, 14, 945, 10.1111/acel.12380 · DOI
- Verstovsek, 2010, Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis, N. Engl. J. Med., 363, 1117, 10.1056/NEJMoa1002028 · DOI · Paper page
- Sunderland, 2023, Senolytics rejuvenate the reparative activity of human cardiomyocytes and endothelial cells, J. Cardiovasc. Aging, 3, 21
- Panchal, 2012, Quercetin ameliorates cardiovascular, hepatic, and metabolic changes in diet-induced metabolic syndrome in rats, J. Nutr., 142, 1026, 10.3945/jn.111.157263 · DOI · Paper page
- Alfonso, 2022, Pharmacological senolysis reduces doxorubicin-induced cardiotoxicity and improves cardiac function in mice, Pharmacol. Res., 183, 106356, 10.1016/j.phrs.2022.106356 · DOI
- Iske, 2020, Senolytics prevent mt-DNA-induced inflammation and promote the survival of aged organs following transplantation, Nat. Commun., 11, 4289, 10.1038/s41467-020-18039-x · DOI · Paper page
- Jia, 2020, Senolytic Agent Navitoclax Inhibits Angiotensin II-Induced Heart Failure in Mice, J. Cardiovasc. Pharmacol., 76, 452, 10.1097/FJC.0000000000000878 · DOI · Paper page
- Xintarakou, 2020, Atrial fibrosis as a dominant factor for the development of atrial fibrillation: Facts and gaps, Europace, 22, 342, 10.1093/europace/euaa009 · DOI
- Adili, 2022, Atrial Fibrillation Underlies Cardiomyocyte Senescence and Contributes to Deleterious Atrial Remodeling during Disease Progression, Aging Dis., 13, 298, 10.14336/AD.2021.0619 · DOI
- Jesel, L., Abbas, M., Park, S.H., Matsushita, K., Kindo, M., Hasan, H., Auger, C., Sato, C., Ohlmann, P., and Mazzucotelli, J.P. (2019). Atrial Fibrillation Progression Is Associated with Cell Senescence Burden as Determined by p53 and p16 Expression. J. Clin. Med., 9. · DOI
- Wang, 2021, Quercetin improves atrial fibrillation through inhibiting TGF-β/Smads pathway via promoting MiR-135b expression, Phytomedicine, 93, 153774, 10.1016/j.phymed.2021.153774 · DOI
- Liu, 2019, Fisetin Alleviates Atrial Inflammation, Remodeling, and Vulnerability to Atrial Fibrillation after Myocardial Infarction, Int. Heart J., 60, 1398, 10.1536/ihj.19-131 · DOI
- Xie, 2017, Premature senescence of cardiac fibroblasts and atrial fibrosis in patients with atrial fibrillation, Oncotarget, 8, 57981, 10.18632/oncotarget.19853 · DOI · Paper page
- Lee, 2021, Local delivery of a senolytic drug in ischemia and reperfusion-injured heart attenuates cardiac remodeling and restores impaired cardiac function, Acta Biomater., 135, 520, 10.1016/j.actbio.2021.08.028 · DOI
- Salerno, 2022, Pharmacological clearance of senescent cells improves cardiac remodeling and function after myocardial infarction in female aged mice, Mech. Ageing Dev., 208, 111740, 10.1016/j.mad.2022.111740 · DOI
- Makkar, 2012, Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): A prospective, randomised phase 1 trial, Lancet, 379, 895, 10.1016/S0140-6736(12)60195-0 · DOI · Paper page
- Hare, 2017, Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM Trial, J. Am. Coll. Cardiol., 69, 526, 10.1016/j.jacc.2016.11.009 · DOI · Paper page
- Alexandre, 2020, Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio-Oncology Guidelines, J. Am. Heart Assoc., 9, e018403, 10.1161/JAHA.120.018403 · DOI · Paper page
- Zamorano, 2016, 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC), Eur. Heart J., 37, 2768, 10.1093/eurheartj/ehw211 · DOI · Paper page
- Bulten, 2019, Cardiac molecular pathways influenced by doxorubicin treatment in mice, Sci. Rep., 9, 2514, 10.1038/s41598-019-38986-w · doi:10.1038/s41598-019-38986-w
- Shi, 2016, Digoxin reduces atherosclerosis in apolipoprotein E-deficient mice, Br. J. Pharmacol., 173, 1517, 10.1111/bph.13453 · DOI · Paper page
- Lazaro, 2015, Targeting HSP90 Ameliorates Nephropathy and Atherosclerosis Through Suppression of NF-κB and STAT Signaling Pathways in Diabetic Mice, Diabetes, 64, 3600, 10.2337/db14-1926 · DOI · Paper page
- Kim, 2022, A Senolytic-Eluting Coronary Stent for the Prevention of In-Stent Restenosis, ACS Biomater. Sci. Eng., 8, 1921, 10.1021/acsbiomaterials.1c01611 · DOI
- Parvizi, 2021, Senolytic agents lessen the severity of abdominal aortic aneurysm in aged mice, Exp. Gerontol., 151, 111416, 10.1016/j.exger.2021.111416 · DOI
- Tateno, 2008, Cell therapy for cardiovascular diseases, Ann. Vasc. Dis., 1, 66, 10.3400/avd.AVDsr00108 · doi:10.3400/avd.avdsr00108
- Oda, 2010, Establishment of culturing system for ex-vivo expansion of angiogenic immature erythroid cells, and its application for treatment of patients with chronic severe lower limb ischemia, J. Mol. Cell. Cardiol., 49, 347, 10.1016/j.yjmcc.2010.04.001 · DOI
- Tateno, 2006, Critical roles of muscle-secreted angiogenic factors in therapeutic neovascularization, Circ. Res., 98, 1194, 10.1161/01.RES.0000219901.13974.15 · DOI · Paper page
- Forman, 2021, Cardiovascular care of older adults, Bmj, 374, n1593
- Young, 2002, Blood pressure and decline in kidney function: Findings from the Systolic Hypertension in the Elderly Program (SHEP), J. Am. Soc. Nephrol., 13, 2776, 10.1097/01.ASN.0000031805.09178.37 · DOI · Paper page
- Izzo, 2000, Clinical Advisory Statement. Importance of systolic blood pressure in older Americans, Hypertension, 35, 1021, 10.1161/01.HYP.35.5.1021 · DOI · Paper page
- Higashi, 2012, Endothelial dysfunction and hypertension in aging, Hypertens. Res., 35, 1039, 10.1038/hr.2012.138 · DOI · Paper page
- Kawaguchi, 2021, Cellular senescence promotes cancer metastasis by enhancing soluble E-cadherin production, iScience, 24, 103022, 10.1016/j.isci.2021.103022 · DOI
- Asaithamby, 2022, Cellular senescence and lung cancer prognosis, Transl. Lung Cancer Res., 11, 1982, 10.21037/tlcr-22-678 · DOI
- Mikawa, 2018, Elimination of p19(ARF) -expressing cells protects against pulmonary emphysema in mice, Aging Cell, 17, e12827, 10.1111/acel.12827 · DOI · Paper page
- Wyles, 2023, A chronic wound model to investigate skin cellular senescence, Aging, 15, 2852
- Dańczak-Pazdrowska, A., Gornowicz-Porowska, J., Polańska, A., Krajka-Kuźniak, V., Stawny, M., Gostyńska, A., Rubiś, B., Nourredine, S., Ashiqueali, S., and Schneider, A. (2023). Cellular senescence in skin-related research: Targeted signaling pathways and naturally occurring therapeutic agents. Aging Cell, e13845. · DOI
- Kirkland, 2023, Tumor dormancy and disease recurrence, Cancer Metastasis Rev., 42, 9, 10.1007/s10555-023-10096-0 · DOI
- Rahman, 2022, Selective Vulnerability of Senescent Glioblastoma Cells to BCL-XL Inhibition, Mol. Cancer Res., 20, 938, 10.1158/1541-7786.MCR-21-0029 · DOI
- Prasanna, 2021, Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy, J. Natl. Cancer Inst., 113, 1285, 10.1093/jnci/djab064 · DOI · Paper page
Cited by
The senescence-associated secretory phenotype and its physiological and pathological implications
Wang, B., Han, J., Elisseeff, J. H., & Demaria, M. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00727-x · Cited by 948
Iron accumulation drives fibrosis, senescence and the senescence-associated secretory phenotype
Maus, M., López-Polo, V., Mateo, L., Lafarga, M., Aguilera, M., De Lama, E., Meyer, K., Sola, A., Lopez-Martinez, C., López-Alonso, I., et al. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00928-2 · Cited by 215
Rejuvenation Strategy for Inducing and Enhancing Autoimmune Response to Eliminate Senescent Cells
Wang, X., Zhang, C., Su, J., Ren, S., Wang, X., Zhang, Y., Yuan, Z., He, X., Wu, X., Li, M., et al. (2025) · Aging and disease · doi:10.14336/ad.2024.0579 · Cited by 8
Bertoli, G., Phadke, K., Cospito, A., Rizk, J. A., Zhang, M., Miliotou, E., Cammer, M., Deng, Y., Mezzano, V., Alu, M., et al. (2025) · doi:10.1101/2025.10.22.682160 · Cited by 2
(2026) · doi:10.1161/jaha.125.047447 · Cited by 2
Metadata
- Authors
- Suda, M., Paul, K. H., Minamino, T., Miller, J. D., Lerman, A., Ellison-Hughes, G. M., Tchkonia, T., & Kirkland, J. L.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2023-05-02
- Volume
- 12
- Issue
- 9
- Pages
- 1296
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W4368405370
- Cited by
- 112
- References
- 137
- FWCI
- 16.22
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- US National Institutes of Health (R37AG013925, R33AG061456, R01AG072301, R01AG061414, R01DK120292, R01AG068048, R01AG064165, P01AG062413, UH3AG056933, 20H00533, 22K18389, JP22gm1110012, 22zf0127003s0201, RG2681, 860034)
- a Grant-in-Aid for Scientific Research (A) (R37AG013925, R33AG061456, R01AG072301, R01AG061414, R01DK120292, R01AG068048, R01AG064165, P01AG062413, UH3AG056933, 20H00533, 22K18389, JP22gm1110012, 22zf0127003s0201, RG2681, 860034)
- Grant-in-Aid for Challenging Research (Pioneering) (R37AG013925, R33AG061456, R01AG072301, R01AG061414, R01DK120292, R01AG068048, R01AG064165, P01AG062413, UH3AG056933, 20H00533, 22K18389, JP22gm1110012, 22zf0127003s0201, RG2681, 860034)
- MEXT, AMED-CREST (R37AG013925, R33AG061456, R01AG072301, R01AG061414, R01DK120292, R01AG068048, R01AG064165, P01AG062413, UH3AG056933, 20H00533, 22K18389, JP22gm1110012, 22zf0127003s0201, RG2681, 860034)
- the Moonshot Research and Development Program (R37AG013925, R33AG061456, R01AG072301, R01AG061414, R01DK120292, R01AG068048, R01AG064165, P01AG062413, UH3AG056933, 20H00533, 22K18389, JP22gm1110012, 22zf0127003s0201, RG2681, 860034)
- Heart Research (R37AG013925, R33AG061456, R01AG072301, R01AG061414, R01DK120292, R01AG068048, R01AG064165, P01AG062413, UH3AG056933, 20H00533, 22K18389, JP22gm1110012, 22zf0127003s0201, RG2681, 860034)
- King’s Together Fund Strategic Award, and ‘RENOIR’, the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie (R37AG013925, R33AG061456, R01AG072301, R01AG061414, R01DK120292, R01AG068048, R01AG064165, P01AG062413, UH3AG056933, 20H00533, 22K18389, JP22gm1110012, 22zf0127003s0201, RG2681, 860034)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Senescent Cells: A Therapeutic Target in Cardiovascular Diseases. https://app.cochat.ai/papers/10.3390/cells12091296
- The paper
- Suda, M., Paul, K. H., Minamino, T., Miller, J. D., Lerman, A., Ellison-Hughes, G. M., Tchkonia, T., & Kirkland, J. L. (2023). Senescent Cells: A Therapeutic Target in Cardiovascular Diseases. Cells. https://doi.org/10.3390/cells12091296
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.